pergolide has been researched along with aldosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhamid, S; Jungmann, E; Schöffling, K; Schumm-Draeger, PM; Timm, C | 1 |
| Althoff, PH; Fassbinder, W; Haak, T; Jungmann, E; Schöffling, K | 1 |
1 trial(s) available for pergolide and aldosterone
| Article | Year |
|---|---|
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy
Topics: Adult; Aged; Aldosterone; Blood Pressure; Bromocriptine; Catecholamines; Dopamine; Female; Humans; Kidney; Male; Middle Aged; Norepinephrine; Pergolide; Pituitary Neoplasms; Prolactin; Renin; Stimulation, Chemical | 1988 |
1 other study(ies) available for pergolide and aldosterone
| Article | Year |
|---|---|
Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue.
Topics: Adenoma; Aldosterone; Animals; Atrial Natriuretic Factor; Haloperidol; Humans; Mice; Mice, Nude; Natriuresis; Neoplasm Transplantation; Pergolide; Receptors, Dopamine | 1986 |